文献速递关节外科

双侧分期全关节置换第二次手术时机对住院不良事件及围术期结局的影响

Does the Timing of the Second Surgery of a Staged Bilateral Total Joint Arthroplasty Affect the Rate of Hospital Adverse Events and Perioperative Outcomes?
PubMed 文献 · J Arthroplasty · 2020-01-17

该回顾性研究纳入670例由2名术者于2010—2016年在单中心连续完成的初次分期双侧全髋/全膝关节置换,分析第二次手术距第一次的间隔(设90天、180天、365天三个阈值)与围术期结局的关系。90天或180天阈值下各结局无显著差异;365天阈值下,间隔≤1年的第二次手术住院时间更长、不良事件及输血率更高。结论提示间隔超过一年可能改善住院结局,但若患者不愿等待一年,90/180天内推进手术未见不良事件风险增加。

要点

  • 以90天或180天为阈值分组时,第二次关节置换的围术期结局无显著差异。
  • 间隔≤1年的第二次手术住院时间、不良事件及输血率显著高于间隔>1年者。
  • 证据等级为Level III,属回顾性研究,结论需谨慎外推。

核心结论

  • 第二次关节置换与第一次间隔超过一年可能带来更短的住院时间和更低的不良事件及输血率。
  • 若患者不愿等待一年,在90天或180天前后进行第二次手术未见不良事件风险增加。

研究设计与样本

  • 回顾性队列研究,纳入2010—2016年单中心由2名术者连续完成的670例初次分期双侧全髋/全膝关节置换。
  • 第二次关节置换共335例,按距对侧第一次手术的时间以90天、180天、365天三个阈值分组比较围术期结局。
  • 证据等级为Level III。

主要发现

  • 以90天或180天为阈值比较时,各结局均无显著差异。
  • 以365天为阈值时,间隔≤1年的第二次手术平均住院时间2.21天 vs 1.92天(P = .015)。
  • 以365天为阈值时,间隔≤1年的第二次手术不良事件率26% vs 15.3%(P = .021)。
  • 以365天为阈值时,间隔≤1年的第二次手术总输血率7.4% vs 1.5%(P = .020),异体输血率6.9% vs 1.5%(P = .033)。

关键数值与推荐

  • 研究采用90天、180天、365天三个时间阈值划分第二次手术的间隔分组。
  • 评估指标包括人口学资料、住院时间、出院去向、不良事件(如恶心、肺栓塞)及输血率。

临床怎么用

  • 在安排分期双侧全关节置换的第二次手术时,可结合患者意愿与等待一年的潜在获益进行个体化决策。
  • 若患者希望在90天或180天左右完成第二次手术,本研究数据未提示不良事件风险增加。

局限性

  • 原文未报告本研究的具体局限性描述。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The optimal timing of the second surgery in primary staged bilateral total hip/knee arthroplasty remains uncertain. Perioperative hospital adverse events represent a significant issue, even "minor events" lead to substantial costs in workup tests, interconsultations, and/or increased hospital length-of-stay (LOS). Therefore, we sought to ascertain whether the timing of the second arthroplasty affects perioperative outcomes and/or rates of adverse events. METHODS: We retrospectively reviewed a consecutive series of 670 primary staged bilateral total hip/knee arthroplasty performed by 2 surgeons (2010-2016) at a single institution. The days between both arthroplasties were calculated for each pair of hips or knees. We evaluated demographics and LOS, discharge disposition, adverse events (ie, nausea, pulmonary embolism), and transfusion rates. The second arthroplasties (n = 335) were set apart in 2 groups based on the time they were done with respect to their corresponding contralateral first arthroplasty using 3 different thresholds: (1) ≤90 vs >90 days, (2) ≤180 vs >180 days, and (3) ≤365 vs >365 days. RESULTS: No significant differences in outcome comparisons were observed using either 90 or 180 days thresholds. However, using the 365 days thresholds, the mean LOS (2.21 vs 1.92 days, P = .015), adverse event (26% vs 15.3%, P = .021), total transfusion (7.4% vs 1.5%, P = .020), and allogeneic transfusion (6.9% vs 1.5%, P = .033) rates were significantly higher in second arthroplasties performed at or less than 1 year apart from the first, respectively. CONCLUSION: Staging the second arthroplasty more than a year apart from the first one seems to offer better LOS and rates of hospital adverse events, transfusions. However, unless patients are willing to wait a year between surgeries, our data also suggest no increased risk in regards to adverse events when proceeding before or after 90/180 days. LEVEL OF EVIDENCE: Level III.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Villa JM, Pannu TS, Higuera CA, et al. Does the Timing of the Second Surgery of a Staged Bilateral Total Joint Arthroplasty Affect the Rate of Hospital Adverse Events and Perioperative Outcomes? J Arthroplasty. 2020. PMID: 32061475. doi:10.1016/j.arth.2020.01.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。